Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study-Reference-Cited by-同舟云学术

Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study

Published:2016-06-02 Issue:8 Volume:54 Page:638-643
ISSN:1556-3650
Container-title:Clinical Toxicology
language:en
Short-container-title:Clinical Toxicology

Author:

Hill Simon L.,Najafi Javad,Dunn Michael,Acheampong Paul,Kamour Ashraf,Grundlingh Johann,Blain Peter G.,Thomas Simon H. L.

Funder

National Institute for Health Research

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15563650.2016.1190980

Reference13 articles.

1. European Monitoring Centre for Drugs and Drug Addiction. New psychoactive substances in Europe. An update from the EU Early Warning System [Internet]; 2015 [cited 2016 May 5]. Available from: http://www.emcdda.europa.eu/system/files/publications/65/TD0415135ENN.pdf.

2. Synthetic Cannabinoid–Related Illnesses and Deaths

3. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

4. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies;Psychoactives;2024-08-03

2. NPS pharmacology and toxicology;Designer Drugs;2024

3. A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia – Victoria (EDNAV) project;International Journal of Drug Policy;2023-12

4. Cannabinoids and Brain Damage: A Systematic Review on a Frequently Overlooked Issue;Current Pharmaceutical Biotechnology;2023-05

5. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019;Clinical Toxicology;2022-11-02